Publications by authors named "Shufei Yu"

Claim this Profile
N
NMR characterization and anti-inflammatory activity of lignans isolated from the roots of Solanum Verbascifolium L.
Jin-Na Zhao, Shu-Fei Yu, Yan-Jun Ding, Bo Li, Jin-Hui Wang

Fitoterapia· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amomaxyz A and B, Sesquiterpene-Indole Alkaloids from Fruits of Roxb.
Shu-Fei Yu, Jin-Na Zhao, Bo Li, Yan-Jun Ding, Ming-Yue He

J Nat Prod· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seven Anti-Inflammatory Diarylheptanoid-Indole Alkaloid Hybrids from the Fruits of .
Shu-Fei Yu, Jin-Na Zhao, Bo Li, Yan-Jun Ding, Lu Chen

Org Lett· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical Constituents from the Heartwood of Solanum Verbascifolium L. And Their Anti-Inflammatory Activities Combined Network Pharmacology.
Jin-Na Zhao, Shu-Fei Yu, Zhi-Hang Wu, Lu Chen, Rong Fu

Chem Biodivers· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seven undescribed compounds from the flower heads of Helianthus annuus L.
Jiaxuan Bai, Xianmei Piao, Yanli Wang, Xiaoling Cheng, Mingfeng Feng, Shufei Yu

Phytochemistry· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organ-specific immune checkpoint inhibitor treatment in lung cancer: a systematic review and meta-analysis.
Shufei Yu, Shuyang Zhang, Haiyan Xu, Guangjian Yang, Fei Xu, Guangyu An

BMJ Open· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Adjuvant Radiation Dose on Survival in Patients with Esophageal Squamous Cell Carcinoma.
Weiming Han, Xiao Chang, Wencheng Zhang, Jingsong Yang, Shufei Yu, Yu Lin

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative Adjuvant Therapy Versus Surgery Alone for Stage IIB-III Esophageal Squamous Cell Carcinoma: A Phase III Randomized Controlled Trial.
Wenjie Ni, Shufei Yu, Zefen Xiao, Zongmei Zhou, Dongfu Chen, Yushun Gao

Oncologist· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrence risk stratification based on a competing-risks nomogram to identify patients with esophageal cancer who may benefit from postoperative radiotherapy.
Xiao Chang, Junqiang Chen, Wencheng Zhang, Jinsong Yang, Shufei Yu, Yu Lin, Yushun Gao, Feiyue Feng

Ther Adv Med Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC.
Zuxiong Tang, Jun He, Jiayue Zou, Shufei Yu, Xiaoming Sun

PeerJ· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
Wenjie Ni, Shufei Yu, Wencheng Zhang, Zefen Xiao, Zongmei Zhou

BMC Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy.
Shufei Yu, Wencheng Zhang, Wenjie Ni, Zefen Xiao, Qifeng Wang

Radiother Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nomogram to Predict Overall Survival for Thoracic Esophageal Squamous Cell Carcinoma Patients After Radical Esophagectomy.
Wei Deng, Wencheng Zhang, Jinsong Yang, Wenjie Ni, Shufei Yu, Yu Lin, Guiyu Cheng

Ann Surg Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant radiotherapy for stage pN1M0 esophageal squamous cell carcinoma: Results from a Chinese two-center study.
Wenjie Ni, Junqiang Chen, Zefen Xiao, Shufei Yu, Wencheng Zhang, Yu Lin, Guiyu Cheng

Thorac Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programmed death-ligand 1 is prognostic factor in esophageal squamous cell carcinoma and is associated with epidermal growth factor receptor.
Wencheng Zhang, Qingsong Pang, Xiaodong Zhang, Cihui Yan, Qifeng Wang, Shufei Yu, Zhiyong Yuan

Cancer Sci· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of PD-L1 expression by epidermal growth factor receptor-mediated signaling in esophageal squamous cell carcinoma.
Wencheng Zhang, Qingsong Pang, Cihui Yan, Qifeng Wang, Jingsong Yang, Shufei Yu, Zhiyong Yuan

Onco Targets Ther· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nomogram and recursive partitioning analysis to predict overall survival in patients with stage IIB-III thoracic esophageal squamous cell carcinoma after esophagectomy.
Shufei Yu, Wencheng Zhang, Wenjie Ni, Zefen Xiao, Xin Wang

Oncotarget· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual lymph node status is an independent prognostic factor in esophageal squamous cell Carcinoma with pathologic T0 after preoperative radiotherapy.
Qifeng Wang, Shufei Yu, Zefen Xiao, Xiao Liu, Wencheng Zhang

Radiat Oncol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Efficacy of chemotherapy after EGFR-TKIs resistance in 191 patients with Unknow EGFR gene mutation in advanced lung adenocarcinoma].
Ping He, Yan Wang, Sheng Yang, Shufei Yu, Ziping Wang, Hongyu Wang, Yuankai Shi

Zhongguo Fei Ai Za Zhi· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A retrospective study of the efficacy and toxicity of irinotecan in combination with nedaplatin versus irinotecan in combination with cisplatin as salvage
treatment in refractory or relapsed small cell lung cancer].
Shufei Yu, Yan Wang, Xingsheng Hu, Hongyu Wang, Xuezhi Hao, Yuankai Shi

Zhongguo Fei Ai Za Zhi· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gefitinib versus erlotinib as salvage treatment for lung adenocarcinoma patients who benefited from the initial gefitinib: A retrospective study.
Shufei Yu, Yan Wang, Junling Li, Xuezhi Hao, Bin Wang, Yuankai Shi

Thorac Cancer· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Randomize trial of cisplatin plus gemcitabine with either sorafenib or placebo as first-line therapy for non-small cell lung cancer].
Yan Wang, Lin Wang, Yutao Liu, Shufei Yu, Xiangru Zhang, Yuankai Shi

Zhongguo Fei Ai Za Zhi· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis